Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens-Reference-Cited by-同舟云学术

Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens

Published:2020-09-01 Issue:9 Volume:6 Page:1372
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Nagpal Kunal¹,Foote Davis¹,Tan Fraser¹,Liu Yun¹,Chen Po-Hsuan Cameron¹,Steiner David F.¹,Manoj Naren¹²,Olson Niels³,Smith Jenny L.³,Mohtashamian Arash³,Peterson Brandon³,Amin Mahul B.⁴,Evans Andrew J.⁵,Sweet Joan W.⁵,Cheung Carol⁵,van der Kwast Theodorus⁵,Sangoi Ankur R.⁶,Zhou Ming⁷,Allan Robert⁸,Humphrey Peter A.⁹,Hipp Jason D.¹¹⁰,Gadepalli Krishna¹,Corrado Greg S.¹,Peng Lily H.¹,Stumpe Martin C.¹¹¹,Mermel Craig H.¹

Affiliation:

1. Google Health, Google LLC, Mountain View, California

2. now with Toyota Technological Institute Chicago, Chicago, Illinois

3. Laboratory Department, Naval Medical Center San Diego, San Diego, California

4. Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis

5. Department of Pathology, Laboratory Medicine and Pathology, University Health Network and University of Toronto, Toronto, Ontario, Canada

6. Department of Pathology, El Camino Hospital, Mountain View, California

7. Tufts Medical Center, Boston, Massachusetts

8. Pathology and Laboratory Medicine Service, North Florida/South Georgia Veterans Health System, Gainesville, Florida

9. Department of Pathology, Yale School of Medicine, New Haven, Connecticut

10. now with AstraZeneca, Gaithersburg, MD

11. now with Tempus, Inc, Redwood Shores, California